TissueGnostics will be at the ASI 2025 meeting, 1–5 December in Perth, Australia. Join one of the region’s largest immunology events and meet our team to discuss your imaging needs.

TissueGnostics’ industry session at IUIS 2025 was a success, uniting immunologists around advances in spatial biology and AI-powered imaging. Thanks to Dr. Ecker, A/Prof. Mechtcheriakova, Prof. Batra, and all who joined us. Until next time!

TissueGnostics proudly participated in the recent mid-term meeting and first doctoral school of the Horizon Europe Marie Skłodowska-Curie Doctoral Network (DN) project eRaDicate.

TG joins SMART CRC as an industrial partner. This $238M initiative accelerates curative therapies for cancer, heart disease, Alzheimer’s, arthritis, and age-related conditions.

TissueGnostics and CrestOptics hosted a webinar demonstrating how TissueFAXS Confocal Cytometers integrate high-throughput imaging, modular workflows, and real-world applications in biomedical research.

Dr. Lukas Kenner, Medical University of Vienna, discusses the impact of micro- and nanoplastic particles on human health, in particular potential effect on cancer development.

The eRaDicate project was launched to test novel nuclear-receptor targeting drugs as anti-cancer agents, such as the retinoic acid receptor (RAR) and the vitamin D receptor (VDR) using a variety of molecular biology methods. TissueGnostics is the official industry beneficiary of the project.

As part of MTPConnect’s Researcher Exchange and Development Within Industry (REDI) initiative, Australian Prof. Jyotsna Batra, an expert in molecular genetics of prostate cancer, formally joined forces with TissueGnostics for a two years project to develop a clinical in-situ test for prostate cancer diagnostics.

TissueGnostics Global expands with TissueGnostics Australia, strengthening partnerships in life sciences across Australia and New Zealand.

HELICAL trained 15 early researchers, published 29 papers, and launched 2 EU projects, advancing healthcare data linkage and GDPR-compliant clinical usage.

The EU-funded SSBB project will train 15 early-stage researchers in drug development, infectiology, and immunology. TissueGnostics contributes as an industry partner to support preclinical testing and antibiotic tracking.

QUAREP-LiMi releases standardized guidelines for light microscopy. Dr. Rupert Ecker contributed to checklists improving image quality, reproducibility, and communication.

TG is a member of the Euro BioImaging Industry Board - on the the Africa Microscopy Initiative (AMI) funded by Chan Zuckerberg Initiative and the Melinda and Bill Gates Foundation. Read more below.

TissueGnostics is pleased to announce that we have become a new associated company of the Brazilian Society of Microscopy and Microanalysis (SBMM). Read more about the goals of the partnership below.

The Institute of Pathophysiology and Allergy Research (MedUni Vienna) has been named a Center of Excellence for Quantitative Digital Microscopy by TissueGnostics, recognizing its pioneering use of the TissueFAXS platform in over 45 high-impact publications.

TG and the University Clinic of Dentistry (Danube Private University) have received FFG funding for AutOPathStage. This project aims to develop a deep learning–based decision support system for classification of oral dysplasia – a disease of the oral cavity with malignant potential.

TG joins the FFG-funded COMET project microONE, investigating how micro- and nanoplastics may influence carcinogenesis and tumor progression. This pioneering research could have broad implications for human health.